Interventions for treating oral mucositis for patients with cancer receiving treatment

Cochrane Database of Systematic Reviews

Volumn , Issue 2, 2007, Pages

  Clarkson, J E ^a   Worthington, Helen V ^a   Eden, O B ^b  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b NONE

Author keywords

Humans; Mouth diseases etiology; therapy ; Mouth mucosa; Neoplasms *therapy ; Pain etiology; therapy ; Randomized controlled trials as topic; Stomatitis complications; *therapy

Indexed keywords

ACETYLSALICYLIC ACID CALCIUM; ALFENTANIL; ALLOPURINOL; ALPHA TOCOPHEROL; ALUMINUM HYDROXIDE; ANALGESIC AGENT; ANTIFUNGAL AGENT; ANTINEOPLASTIC AGENT; BENZYDAMINE; CHLORHEXIDINE; DIPHENHYDRAMINE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HYDROMORPHONE; IMMUNOGLOBULIN; LIDOCAINE; MORPHINE; OPIATE; PLACENTA EXTRACT; POVIDONE IODINE; SUCRALFATE; SUFENTANIL; TETRACHLORODECAOXIDE;

ANALGESIA; CANCER CHEMOTHERAPY; CANCER CLASSIFICATION; CANCER RADIOTHERAPY; CLINICAL FEATURE; CLINICAL TRIAL; CONFIDENCE INTERVAL; DISEASE ASSOCIATION; DISEASE CONTROL; DISEASE DURATION; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DYSPHAGIA; HOSPITALIZATION COST; HUMAN; INFECTION; INTERVENTION STUDY; MEDICAL INFORMATION; MEDICAL LITERATURE; MEDICAL RESEARCH; MOUTH PAIN; MUCOSA INFLAMMATION; NEOPLASM; PRESCRIPTION; QUALITY OF LIFE; REVIEW; RISK ASSESSMENT; CONTROLLED CLINICAL TRIAL; META ANALYSIS; MOUTH DISEASE; MOUTH MUCOSA; PAIN; RANDOMIZED CONTROLLED TRIAL; STOMATITIS;

HUMANS; MOUTH DISEASES; MOUTH MUCOSA; NEOPLASMS; PAIN; RANDOMIZED CONTROLLED TRIALS; STOMATITIS;

EID: 34447341507     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD001973.pub3     Document Type: Review

References (120)

1. Chiara 2001 {published data only} Chiara S, Nobile MT, Vincenti M, Gozza A, Pastrone I, Rosso M, et al. Sucralfate in the treatment of chemotherapy-induced stomatitis: a double-blind, placebo-controlled pilot study. Anticancer Research 2001;21(5):3707-10.
2. Coda 1997 {published data only} Coda BA, O'Sullivan B, Donaldson G, Bohl S, Chapman CR, Shen DD. Comparative efficacy of patient-controlled administration of morphine, hydromorphone, or sufentanil for the treatment of oral mucositis pain following bone marrow transplantation. Pain 1997;72:333-46.
3. Dodd 2000 {published data only} Dodd MJ, Dibble SL, Miaskowski C, MacPhail L, Greenspan D, Paul SM, et al. Randomized clinical trial of the effectiveness of 3 commonly used mouthwashes to treat chemotherapy-induced mucositis. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, & Endodontics 2000;90(1):39-47.
4. Dodd 2003 {published data only} Dodd MJ, Miaskowski C, Greenspan D, MacPhail L, Shih AS, Shiba G. Radiation-induced mucositis: a randomized clinical trial of micronized sucralfate versus salt & soda mouthwashes. Cancer Investigations 2003;21(1):21-33.
5. Ehrnrooth 2001 {published data only} Ehrnrooth E, Grau C, Zachariae R, Andersen J. Randomized trial of opioids versus tricyclic antidepressants for radiation-induced mucositis pain in head and neck cancer. Acta Oncologica 2001;40(6):745-50.
6. Hejna 2001 {published data only} Hejna M, Kostler WJ, Raderer M, Steger GG, Brodowicz T, Scheithauer W, et al. Decrease of duration and symptoms in chemotherapy-induced oral mucositis by topical GM-CSF: results of a prospective randomised trial. European Journal of Cancer 2001;37(16):1994-2002.
7. Hill 1990 {published data only} Hill HF, Chapman CR, Kornell JA, Sullivan KM, Saeger LC, Benedetti C. Self-administration of morphine in bone marrow transplant patients reduces drug requirement. Pain 1990;40:121-9.
8. Hill 1991 {published data only} Hill HF, Mackie AM, Coda BA, Iverson K, Chapman CR. Patient-controlled analgesic administration. A comparison of steady-state morphine infusions with bolus doses. Cancer 1991;67(4):873-82.
9. Hill 1992 {published data only} Hill HF, Coda BA, Mackie AM, Iverson K. Patient-controlled analgesic infusions: alfentanil versus morphine. Pain 1992;49:301-10.
10. Kaushal 2001 {published data only} Kaushal V, Verma K, Manocha S, Hooda HS, Das BP. Clinical evaluation of human placental extract (placentrex) in radiation-induced oral mucositis. International Journal of Tissue Reaction 2001;23(3):105-10.
11. Kim 1985 {published data only} *Kim JH, Chu F, Houde R. A clinical study of benzydamine for the treatment of radiotherapy-induced mucositis of the oropharynx. International Journal of Tissue Reaction 1985;VII(3):215-8.
12. Kim JH, Chu FC, Lakshmi V, Houde R. Benzydamine HCl, a new agent for the treatment of radiation mucositis of the oropharynx. American Journal of Clinical Oncology 1986;9(2):132-4.
13. Kostrica 2002 {published data only} Kostrica R, Rottenberg J, Kvech J, Betka J, Jablonicky P. Randomised, double-blind comparison of efficacy and tolerability of diclofenac mouthwash versus placebo inmucositis of oral cavity by radiotherapy. Journal of Drug Assessment 2002;5:99-113.
14. Loprinzi 1997 {published data only} Ghosh C, Loprinzi CL, Camoriano J, Sloan J, Steen P, Michalak J, et al. Evaluation of sucralfate for alleviating 5FU induced stomatitis. Proceedings of Annual Meeting American Society for Clinical Oncology. 1996:Abs A1729.
15. *Loprinzi CL, Ghosh C, Camoriano J, Sloan J, Steen PD, Michalak JC, et al. Phase III controlled evaluation of sucralfate to alleviate stomatitis in patients receiving fluorouracil-based chemotherapy. Journal of Clinical Oncology 1997;15(3):1235-8.
16. Mackie 1991 {published data only} Mackie AM, Coda BC, Hill HF. Adolescents use patient-controlled analgesia effectively for relief from prolonged oropharyngeal mucositis pain. Pain 1991;46:265-9.
17. Malik 1997 {published data only} Malik IA, Moid I, Haq S, Sabih M. A double-blind, controlled, randomized trial to evaluate the role of tetrachlorodecaoxide in the management of chemotherapy-induced oral mucositis. Journal of Pain and Symptom Management 1997;14(2):82-7.
18. Masucci 2005 {published data only} Masucci G, Broman P, Kelly C, Lindahl S, Malmberg L, Reizenstein J, et al. Therapeutic efficacy by recombinant human granulocyte/monocyte-colony stimulating factor on mucositis occurring in patients with oral and oropharynx tumors treated with curative radiotherapy: a multicenter open randomized phase III study. Medical Oncology 2005;22(3):247-56.
19. Papila 2003 {published data only} Papila C, Papila I, Yanardag H, Cansiz H, Cagatay P. The use of granulocyte-macrophage colony-stimulating factor (GM-CSF) as a mouthwash in patients with chemotherapy-induced oral mucositis. International Review of Allergology and Clinical Immunology 2003;9:1.
20. Pillitteri 1998 {published data only} Pillitteri LC, Clark RE. Comparison of a patient-controlled analgesia system with continuous infusion for administration of diamorphine for mucositis. Bone Marrow Transplantation 1998;22:495-8.
21. Porta 1994 {published data only} *Porta C, Moroni M, Nastasi G. Allopurinol mouthwashes in the treatment of 5-fluorouracil-induced stomatitis. American Journal of Clinical Oncology 1994;17(3):246- 7.
22. Porta C, Moroni M, Nastasi G, Montecucco CM, Caporali R, Notario A. Allopurinol mouthwashes can reduce oral mucositis in chemotherapy-treated patients. Annals of Oncology 1994;5(Suppl 8):208.
23. Schedler 1994 {published data only} Schedler MGJ, Bost P, Federspil P, Pautler M, Schatzle W. Treatment of radiogenic mucositis in patients with head and neck tumors with polyvalent intramuscular immunoglobulin [Die behandlung der strahleninduzierten mukositis bei kopf-/halstumoren mit intramuskular verabreichtem polyvalentem immunoglobin]. Tumordiagnostik und Therapie 1994;15:184-91.
24. Schubert 1987 {published data only} Schubert MM, Newton RE. The use of benzydamine HCI for the management of cancer therapy-induced mucositis: preliminary report of a multicentre study. International Journal of Tissue Reaction 1987;IX(2):99-103.
25. Syrjala 1992 {published data only} Syrjala KL, Cummings C, Donaldson GW. Hypnosis or cognitive behavioral training for the reduction of pain and nausea during cancer treatment: A controlled clinical trial. Pain 1992;48(2):137-46.
26. Syrjala 1995 {published data only} Syrjala KL, Donaldson GW, Davis MW, Kippes ME, Carr JE. Relaxation and imagery and cognitive-behavioral training reduce pain during cancer treatment: a controlled clinical trial. Pain 1995;63(2):189-98.
27. Valcarcel 2000 {published data only} Valcarcel D, Sanz MA, Sureda A, Sala M, Munoz L, Subira M. Mouth-washings with recombinant human granulocyte-macrophage colony stimulating factor (rhGM-CSF) do not improve grade III-IV oropharyngeal mucositis (OM) in patients with hematological malignancies undergoing stem cell transplantation. Results of a randomized double-blind placebo-controlled study. Bone Marrow Transplantation 2000;29:783-7.
28. Wadleigh 1992 {published data only} Wadleigh RG, Redman RS, Graham ML, Krasnow SH, Anderson A, Cohen MH. Vitamin E in the treatment of chemotherapy-induced mucositis. The American Journal of Medicine 1992;92:481-4.
29. Zucker 1998 {published data only} Zucker TP, Flesche CW, Germing U, Schroter S, Willers R, Wolf HH, et al. Patient-controlled versus staff-controlled analgesia with pethidine after allogeneic bone marrow transplantation. Pain 1998;75(2-3):305-12.
30. Agüeros 2004 Agüeros P, Bárcena M, Del Campo M, Lucero P, Bermudez A, Yanez L. Efficacy of vitamin E during acutemucositis in bone marrow transplantation. Bone Marrow Transplantation 2004;33(Suppl 1):S291.
31. Allison 1995 Allison RR, Vongtama V, Vaughan J, Shin KH. Symptomatic acute mucositis can be minimized or prophylaxed by the combination of sucralfate and fluconazole. Cancer Investigations 1995;13(1): 16-22.
32. Atkins 2004 Atkins MB, Hidalgo M, Stadler WM, Logan TF, Dutcher JP, Hudes GR, et al. Randomized phase II study of multiple dose levels of CCI-779, a novel mammalian target of rapamycin kinase inhibitor, in patients with advanced refractory renal cell carcinoma. Journal of Clinical Oncology 2004;22(5):909-18.
33. Awada 2004 Awada A, Gil T, Sales F, Dubuisson M, Vereecken P, Klastersky J, et al. Prolonged schedule of temozolomide (Temodal) plus liposomal doxorubicin (Caelyx) in advanced solid cancers. Anticancer Drugs 2004;15(5):499-502.
34. Barker 1991 Barker G, Loftus L, Cuddy P, Barker B. The effects of sucralfate suspension and diphenhydramine syrup plus kaolin-pectin on radiotherapy-induced mucositis. Oral Surgery, Oral Medicine, Oral Pathology 1991;71(3):288-93.
35. Beltran 1990 Beltran A, Ochoa Carrillo FJ, Ibieta BR, Fuentes EP, Zeichner I. Double blind controlled study with placebo to demonstrate the efficacy and safety of bencidamide mouth washes for radiation mucositis. Journal of Cancer Research and Clinical Oncology 1990;116 Suppl:639(Abs A5.280.12).
36. Biswal 2002 Biswal BM, Zakaria A, Nik Min A. Topical application of honey in the management of radiation mucositis: A randomised study. International Journal of Cancer 2002;13:480(Abs P1109).
37. Biswal 2003 Biswal BM, Zakaria A, Ahmad NM. Topical application of honey in the management of radiation mucositis: a preliminary study. Supportive Care in Cancer 2003;11(4):242-8.
38. Bondi 1997 Bondi E, Baroni C, Prete A, Gatti M, Carrassi A, Lodi G, et al. Local antimicrobial therapy of oral mucositis in paediatric patients undergoing bonemarrow transplantation. Oral Oncology 1997;33(5): 322-6.
39. Pession A, Prete A, Bondi E, Baroni C, Melchionda F, Riolo U, Paolucci G. Treatment of oralmucositis in children undergoing bone marrow transplantation: comparison between two different regimes. Bone Marrow Transplantation 1997;19(Suppl):S123(Abs P491).
40. Carnel 1990 Carnel SB, Blakeslee DB, Oswald SG, Barnes M. Treatment of radiation- and chemotherapy-induced stomatitis. Otolaryngology - Head & Neck Surgery 1990;102(4):326-30.
41. Cerchietti 2002 Cerchietti LC, Navigante AH, Bonomi MR, Zaderajko MA, Menendez PR, Pogany CE, et al. Effect of topical morphine for mucositis-associated pain following concomitant chemoradiotherapy for head and neck carcinoma. Cancer 2002;95(10):2230-6.
42. Cerchietti 2003 Cerchietti LC, Navigante AH, Bonomi MR, Zaderajko MA, Menendez PR, Pogany CE, et al. Effect of topical morphine for mucositis-associated pain following concomitant chemoradiotherapy for head and neck carcinoma. Cancer 2002;95(10):2230-6.
43. Chapman 1997 Chapman CR, Donaldson GW, Jacobson RC, Hautman B. Differences among patients in opioid self-administration during bone marrow transplantation. Pain 1997;71(3):213-23.
44. Cheng 2004 Cheng KK. Children's acceptance and tolerance of chlorhexidine and benzydamine oral rinses in the treatment of chemotherapy-induced oropharyngealmucositis. European Journal of Oncology Nursing 2004;8(4):341-9.
45. Collins 1996 Collins JJ, Geake J, Grier HE, Houck CS, Thaler HT, Weinstein HJ, et al. Patient-controlled analgesia for mucositis pain in children: a three-period crossover study comparing morphine and hydromorphone. Journal of Pediatrics 1996;129(5):722-8.
46. Collova 2004 Collova E, Castagna L, Nozza A, Perfetti V, Patrone F, Danova M, et al. New approaches for reduction of oral mucositis in patients undergoing high-dose chemotherapy with hematopoietic stem cell support. Bone Marrow Transplantation 2004;33(Suppl 1):S323-S4.
47. Connor 1996 Connor CA, Aston S, Fegan CD, Milligan DW. A comparison of patient controlled analgesia (PCA) versus conventional pain control formucositis after bonemarrow transplantation. Bone Marrow Transplantation 1996;17(Suppl):S161.
48. Crawford 1994 Crawford J, Glaspy J, Vincent M, Tomita D, Mazanet R. Effect of filgrastim (r-metHug-CSF) on oral mucositis in patients with small cell lung cancer (SCLC) receiving chemotherapy (cyclophosphamide, doxorubicin and etoposide, CAE). Proceedings of the Annual Meeing of American Society for Clinical Oncology. 1994;Vol. 13:Abs A1523.
49. Domenge 1999 Domenge C, Lefebvre JL, Esnault Y. Randomized study of fluconozole (FCA) oral suspension (OS) versus amphotericin b (ab) oral suspension in the treatment of oropharingeal mucositis in head and neck cancer patients (HNCP). European Journal of Cancer 1999;35 Suppl(4):161(Abs 603).
50. Ehrnrooth 1999 Ehrnrooth E, Grau C, Zachariae I, Andersen JW. A randomised trial of opioid versus tricyclic antidepressants for radiation induced mucositis pain in patients with head and neck cancer (Abstract). European Journal of Cancer 1999;35 Suppl(4):175(Abs 666).
51. Evans 1998 Evans G, Mahendra P, Brightwell M, Jestice K, Marcus RE. A double blind randomised trial of oral GM-CSF mouthwashes versus placebo in the treatment of mucositis following PBSC / bone marrow transplantation. Bone Marrow Transplantation 1998;21 Suppl(1):S88.
52. Evensen 2001 Evensen JF, Bjordal K, Jacobsen AB, Lokkevik E, Tausjo JE. Effects of Na-sucrose octasulfate on skin andmucosa reactions during radiotherapy of head and neck cancers - a randomized prospective study. Acta Oncologica 2001;40(6):751-5.
53. Ferretti 1987 Ferretti G, Lillich T, Raybould T, Ash R, Henslee J, MacDonald J, et al. Effect of chlorhexidine on the oral complications of patients receiving chemotherapy. Proceedings of Annual Meeting of American Society for Cinical Oncology. 1987; Vol. 6:268(Abs 1053).
54. Foote 1996 Foote RL, Loprinzi CL, Gulavita S, Sloan J, Earle J, Burk M, et al. Randomised trial of a nonabsorbable antibiotic lozenge for alleviation of radiation-induced mucositis. Proceedings of Annual Meeting American Society of Clinical Oncology. 1996:(Abs A1728).
55. Giles 2002 Giles FJ, Hurd DD, Rodriguez R, Weisdorf DJ, Martin PJ, Wingard JR, et al. A phase III, randomized, placebo-controlled, double-blind, multicenter study (RPCDBM) of iseganan HCL oral solution (Iseganan) in reducing severity of oral mucositis (OM) in patients receiving stomatotoxic chemotherapy (CT). Blood 2002;100(11):(Pt 2).
56. Giles 2004 Giles FJ, Rodriguez R, Weisdorf DJ, Wingard JR, Martin PJ, Fleming TR, et al. A phase III, randomized, double-blind, placebo-controlled, study of iseganan for the reduction of stomatitis in patients receiving stomatotoxic chemotherapy. Leukemia Research 2004;28(6):559-65.
57. Girdler 1995 Girdler NM, McGurk M, Aqual S, Prince M. The effect of epidermal growth factor mouthwash on cytotoxic-induced oral ulceration. A phase I clinical trial. American Journal of Clinical Oncology 1995;18(5):403-6.
58. Gobetti 1999 Gobetti JP. Comparison of two commercial products in relieving radiation mucositis discomfort (IADR Abstract 1999). Journal of Dental Research 1999;March Special Issue:518(Abs 3301).
59. Hejna 2000 Hejna M, Kostler W, Raderer M, Steger G, Brodowicz T, Scheithauer W, et al. A prospective randomized trial on the efficacy in GM-CSF mouthwashes for the treatment of chemotherapy- induced oral mucositis. Proceedings of the Annual Meeting of American Society of Clinical Oncology. 2000; Vol. 19:(Abs 2407).
60. Kostler 2005 Kostler WJ, Hejna M, Zielinski CC. Palifermin and chemotherapy-induced oral mucositis. New England Journal of Medicine 2005;352(12):1264-5.
61. Labbate 2003 Labbate R, Lehn CN, Denardin OVP. Effects of chlorhexidine mouthwash on radiation induced mucosistis in head and neck cancer. Revista Brasileira de Otorrinolaringologia 2003;69(3):349-54.
62. Lever 1987 Lever SA, Dupuis LL, Chan HS. Comparative evaluation of benzydamine oral rinse in children with antineoplastic-induced stomatitis. Drug Intelligence for Clinical Pharmacology 1987;21(4):359-61.
63. Lilleby 2006 Lilleby K, Garcia P, Gooley T, McDonnnell P, Taber R, Holmberg L, et al. A prospective, randomized study of cryotherapy during administration of high-dose melphalan to decrease the severity and duration of oral mucositis in patients with multiple myeloma undergoing autologous peripheral blood stem cell transplantation. Bone Marrow Transplantation 2006;37(11):1031-5.
64. Lockhart 2005 Lockhart PB, Brennan MT, Kent ML, Packman CH, Norton HJ, Fox PC, et al. Randomized controlled trial of pilocarpine hydrochloride for the moderation of oral mucositis during autologous blood stem cell transplantation. Bone Marrow Transplantation 2005;35(7):713-20.
65. Mantovani 2003 Mantovani G, Massa E, Astara G, Murgia V, Gramignano G, Lusso MR, et al. Phase II clinical trial of local use of GM-CSF for prevention and treatment of chemotherapy- and concomitant chemoradiotherapy-induced severe oral mucositis in advanced head and neck cancer patients: an evaluation of effectiveness, safety and costs. Oncology Reports 2003;10(1):197-206.
66. Marinoni 1996 Marinoni L, Galletti C, Caruana S, Saccomando A, Castelli N, et al. Treatment of mucositis-related pain in patients undergoing CPC transplantation. Bone Marrow Transplantation 1996;17(Suppl): S168.
67. Meredith 1997 Meredith R, Salter M, Kim R, Spencer S, Weppelmann B, Rodu B, et al. Sucralfate for radiation mucositis: results of a double-blind randomized trial. International Journal of Radiation Oncology, Biology, Physics 1997;37(2):275-9.
68. Meredith R, Salter M, Kim R, Spencer S, Weppelmann B, Rodu B, et al. Sucralfate for radiation mucositis: results of a double-blind randomized trial. International Journal of Radiation Oncology, Biology, Physics 1995;32(S1):285.
69. Mitrokhin 2003 Mitrokhin SD. [Itraconazole (Orungal) in the treatment of mycotic infections in oncological patients]. Antibiotiki i Khimioterapiia 2003;48(2):16-21.
70. Oguchi 1998 Oguchi M, Shikama N, Sasaki S, Gomi K, Katsuyama Y, Ohta S, et al. Mucosa-adhesive water-soluble polymer film for treatment of acute radiation-induced oral mucositis. International Journal of Radiation Oncology, Biology, Physics 1998;40(5):1033-7.
71. Oshitani 1990 Oshitani T, Okada K, Kushima T, Suematsu T, Obayashi K, Hirata Y, et al. [Clinical evaluation of sodium alginate on oral mucositis associated with radiotherapy]. Nippon Gan Chiryo Gakkai Shi 1990;25(6):1129-37.
72. Papila 1999 Papila C, Paplia I, Resuli A, Koksal S. Efficacy of sucralfate in oral mucositis induced by systemic chemotherapy with 5-fluorouracil. Journal of BUON 1999;4:321-3.
73. Pession 1997 Pession A, Prete A. Treatment of oral mucositis in children undergoing bone marrow transplantation: comparison between two different regimen. Bone Marrow Transplantation 1997;19 Suppl:S123 (Abs P489).
74. Pilitteri 1998 *Pillitteri LC, Clark RE. Comparison of a patient-controlled analgesia system with continuous infusion for administration of diamorphine for mucositis. Bone Marrow Transplantation 1998;22(5):495-8.
75. Pillitteri LC, Clark RE. Comparison of a patient controlled analgesia system with continuous infusion for administration of parenteral diamorphine for mucositis. Bone Marrow Transplantation 1996;17(Suppl 1):S169.
76. Pillitteri LC, Clark RE. Comparison of patient-controlled analgesia with continuous diamorphine infusion for mucositis. Bone Marrow Transplantation 1998;21(1):S264.
77. Pillitteri 1996 Pillitteri LC, Clark RE. Comparison of a patient controlled analgesia system with continuous infusion for administration of parenteral diamorphine for mucositis. Bone Marrow Transplantation 1996;17(1):S169.
78. Pouli 1999 Pouli A, Delistrati V, Giannakaki A, Kostelidou D, Pagoni M, Karakasis D, et al. A prospective randomized trial of GM-CSF mouthwash versus sodium bicarbonate mouthwash in the treatment of stomatitis following allogeneic bone marrow transplantation. Bone Marrow Transplantation 1999;23(Suppl 1):S166.
79. Rades 2004 Rades D, Fehlauer F, Bajrovic A, Mahlmann B, Richter E, Alberti W. Serious adverse effects of amifostine during radiotherapy in head and neck cancer patients. Radiotherapy & Oncology 2004;70(3):261-4.
80. Radmard 2002 Radmard A, Niewohner-Desbordes U, Wagner W. [rhGM-CSF in the treatment of radiogenic mucositis: prospective randomised phase-II study on the effectivity and tolerance of rhGM-CSF in the treatment of oral mucositis under radiotherapy of head and neck tumors]. Strahlentherapie und Onkologie 2002;178(Suppl 1):24.
81. Rothwell 1990 Rothwell BR, Spektor WS. Palliation of radiation-related mucositis. Special Care in Dentistry 1990;10(1):21-5.
82. Schmid 2006 Schmid I, Schmitt M, Streiter M, Meilbeck R, Albert MH, Reinhardt D, et al. Parenteral nutrition is not superior to replacement fluid therapy for the supportive treatment of chemotherapy induced oral mucositis in children. European Journal of Cancer 2006;42(2):205- 11.
83. Schwerkkoske 1999 Schwerkkoske J, Schwartzberg L, Weaver CH, Schwertschlag US, Goodfellow J, Berdosian CL. A phase I double-masked, placebo-controlled study to evaluate tolerability of Neumega (rhIL-11; Oprelvekin) to reduce mucositis in patients with solid tumors or lymphoma receiving high-dose chemotherapy (CT) with autologous peripheral blood stem cell reinfusion (PBSCT). Proceedings of the American Society of Clinical Oncology. 1999; Vol. 18:584a.
84. Shaiova 2004 Shaiova L, Lapin J, Manco LS, Shasha D, Hu K, Harrison L, et al. Tolerability and effects of two formulations of oral transmucosal fentanyl citrate (OTFC; ACTIQ) in patients with radiation-induced oral mucositis. Supportive Care in Cancer 2004;12(4):268-73.
85. Sprinzl 2001 Sprinzl GM, Galvan O, de Vries A, Ulmer H, Gunkel AR, Lukas P, et al. Local application of granulocyte-macrophage colony stimulating factor (GM-CSF) for the treatment of oral mucositis. European Journal of Cancer 2001;37(16):2003-9.
86. Stokman 2004 Stokman MA, Wachters FM, Koopmans P, Burgerhof JG, Groen HJ, Spijkervet FK, et al. Outcome of local application of amifostine (WR-1065) on epirubicin-induced oral mucositis. A phase II study. Anticancer Research 2004;24(5B):3263-7.
87. Su 2004 Su YB, Vickers A, Zelefsky MJ, Kraus DH, Shaha AR, Shah JP, et al. Double-blind, randomized trial of granulocyte-colony stimulating factor (GCSF) versus (v.) placebo during postoperative radiation (RT) for advanced resectable squamous cell head and neck cancer (SCCHN): impact on mucositis. Journal of Clinical Oncology 2004;22(Suppl):14S.
88. Svanberg 2004 Svanberg A, Öhrn K. Cryotherapy during chemotherapy - could it delay or alleviate the development of mucositis?. Bone Marrow Transplantation 2004;33(Suppl 1):S292.
89. Teshima 1986 Teshima T. [Clinical evaluation of kenalog ointment for radiation mucositis of patients with head and neck cancer]. Yakuri to Chiryo (Japanese Pharmacology and Therapeutics) 1986;14(11):7163-6.
90. Valcarcel 2002 Valcarcel D, Sanz M, Sureda A, Sala M, Munoz L, Subira M, et al. Topically applied recombinant human granulocyte-macrophage colony stimulating factor (rhGM-CSF) for oropharyngeal mucositis (OM) in stem cell transplantation recipients: a randomized double-blind placebo-controlled study. Bone Marrow Transplantation 2002;(Suppl 2):S20.
91. Vela-Ojeda 1996 Vela-Ojeda J, Tripp-Villaneuva F, Sanchez-Cortes E, Gonzales-Llaven J. Topical oral granulocyte-macrophage colony-stimulating factor (GM-CSF) for the treatment of mucositis after bone marrow transplantation. Blood 1996;88(10):253b.
92. Cerchietti 2006 Cerchietti LC, Navigante AH, Lutteral MA, Castro MA, Kirchuk R, Bonomi M, et al. Double-blinded, placebo-controlled trial on intravenous L-alanyl-L-glutamine in the incidence of oral mucositis following chemoradiotherapy in patients with head-and-neck cancer. International Journal of Radiation Oncology, Biology, Physics 2006;65(5):1330-7.
93. Naidu 2005 Naidu MU, Ramana GV, Ratnam SV, Sudhavani T, Naidu KJ, Roy P, et al. A randomised, double-blind, parallel, placebo-controlled study to evaluate the efficacy of MF 5232 (Mucotrol), a concentrated oral gel wafer, in the treatment of oral mucositis. Drugs in R&D 2005;6(5):291-8.
94. She 2000 She H, Ding Z, Guo QM, Cheng BQ. Prevention and treatment of oral mucositis caused by radiotherapy in patients with nasopharyngeal carcinoma. Journal of Ningxia Medical College 2000;22(2):99-100.
95. Shen 2004 Shen YF, Ma BL, Huang H. Effect of vitamin B12 and dexasone on acute radiation stomatitis. Chinese New Medicine 2004;5(6):509-10.
96. Siddiqui 2005 Siddiqui MA, Wellington K. Palifermin: in myelotoxic therapy-induced oral mucositis. Drugs 2005;65(15):2139-46.
97. Begg 1996 Begg C, Cho M, Eastwood S, Horton R, Moher D, Olkin I, et al. Improving the quality of reporting of randomized controlled trials. The CONSORT statement. JAMA 1996;276(8):637-9.
98. Bellm 2002 Bellm LA, Cunningham G, Durnell L, Eilers J, Epstein JB, Fleming T. Defining clinically meaningful outcomes in the evaluation of new treatments for oralmucositis: oralmucositis patient provider advisory board. Cancer Investigations 2002;20(5-6):793-800.
99. Clarkson 2004 Clarkson JE, Worthington HV, Eden OB. Interventions for treating oral candidiasis for patients with cancer receiving treatment. Cochrane Database of Systematic Reviews 2004, Issue 1.Art. No.: CD001972. DOI:10.1002/14651858.CD001972.pub2.
100. Clarkson 2007 Clarkson JE, Worthington HV, Eden OB. Interventions for preventing oral candidiasis for patients with cancer receiving treatment. Cochrane Database of Systematic Reviews 2007, Issue 1.Art. No.: CD003807. DOI:10.1002/14651858.CD003807.pub3.
101. De Pauw 1997 De Pauw BE. Practical modalities for prevention of fungal infections in cancer patients. European Journal of Clinical Microbiology & Infectious Diseases 1997;16(1):32-41.
102. Denning 1992 Denning DW, Donnelly JP, Hellreigel KP, Ito J, Martino P, van't Wout JW. Antifungal prophylaxis during neutropenia or allogeneic bone marrow transplantation: what is the state of the art? Ad HOC Working Group. Chemotherapy 1992;38 Suppl(1):43-9.
103. Donnelly 2003 Donnelly JP, Bellm LA, Epstein JB, Sonis ST, Symonds RP. Antimicrobial therapy to prevent or treat oral mucositis. Lancet Infectious Diseases 2003;3(7):405-12.
104. Fung 2002 Fung SM, Ferrill MJ. Granulocyte macrophage-colony stimulating factor and oral mucositis. Annals of Pharmacotherapy 2002;36(3):517-20.
105. Higgins 2006 Higgins JPT, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions 4.2.6 [updated September 2006]. The Cochrane Library, Issue 4. Chichester, UK: John Wiley & Sons, Ltd, 2006.
106. Knox 2000 Knox JJ, Puodziunas AL, Feld R. Chemotherapy-induced oral mucositis. Prevention and management. Drugs Aging 2000;17(4):257-67.
107. Kowanko 1998 Kowanko I, Long L, Hodgkinson B, Evans D. The effectiveness of strategies for preventing and treating chemotherapy and radiation induced oral mucositis in patients with cancer. 1-84. Adelaide, S. Australia, Australia: Joanna Briggs Institute for Evidence Based Nursing and Midwifery, 1998.
108. Lortholary 1997 Lortholary O, Dupont B. Antifungal prophylaxis during neutropenia and immunodeficiency. Clinical Microbiology Reviews 1997;10(3):477-504.
109. Moher 2001 Moher D, Schulz KF, Altman DG. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials. Annals of Internal Medicine 2001;134(8):657-62.
110. Plevova 1999 Plevova P. Prevention and treatment of chemotherapy- and radiotherapy-induced oral mucositis: a review. Oral Oncology 1999;35(5):453-70.
111. Shaw 2000 Shaw MJ, Kumar ND, Duggal M, Fiske J, Lewis DA, Kinsella T. Oral management of patients following oncology treatment: literature review. British Journal of Oral & Maxillofacial Surgery 2000;38(5): 519-24.
112. Shih 2002 Shih A, Miaskowski C, Dodd MJ, Stotts NA, MacPhail L. A research review of the current treatments for radiation-induced oral mucositis in patients with head and neck cancer. Oncology Nursing Forum 2002;29(7):1063-80.
113. Stevens 1995 Stevens DA. Therapy for opportunistic fungal infections: past, present and future. Indian Journal of Cancer 1995;32:1-9.
114. Sutherland 2001 Sutherland SE, Browman GP. Prophylaxis of oral mucositis in irradiated head-and-neck cancer patients: a proposed classification scheme of interventions and meta-analysis of randomized controlled trials. International Journal of Radiation Oncology, Biology, Physics 2001;49(4):917-30.
115. Symonds 1998 Symonds RP. Treatment-inducedmucositis: an old problem with new remedies. British Journal of Cancer 1998;77(10): 1689-95.
116. Trotti 2003 Trotti A, Bellm LA, Epstein JB, Frame D, Fuchs HJ, Gwede CK, et al. Mucositis incidence, severity and associated outcomes in patients with head and neck cancer receiving radiotherapy with or without chemotherapy: a systematic literature review. Radiotherapy Oncology 2003;66(3):253-62.
117. Verdi 1993 Verdi CJ. Cancer therapy and oral mucositis. Drug Safety 1993;9(3):185-95.
118. White 1993 White MH. Antifungal prophylaxis. Current Opinions in Infectious Diseases 1993;6:737-43.
119. Worthington 2006 Worthington HV, Clarkson JE, Eden OB. Interventions for preventing oral mucositis for patients with cancer receiving treatment. Cochrane Database of Systematic Reviews 2006, Issue 2.Art. No.: CD000978. DOI:10.1002/14651858.CD000978.pub2.
120. Worthington 2004 Worthington HV, Clarkson JE, Eden OB. Interventions for treating oral mucositis for patients with cancer receiving treatment. Cochrane Database of Systematic Reviews 2004, Issue 2.Art. No.: CD001973. DOI:10.1002/14651858.CD001973.pub2.